These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12428861)

  • 21. Development of morphoea in rheumatoid arthritis treated with penicillamine.
    Liddle BJ
    Ann Rheum Dis; 1989 Nov; 48(11):963-4. PubMed ID: 2596888
    [No Abstract]   [Full Text] [Related]  

  • 22. Two cases of morphea associated with Hashimoto's thyroiditis.
    Lee HJ; Kim MY; Ha SJ; Kim JW
    Acta Derm Venereol; 2002; 82(1):58-9. PubMed ID: 12013202
    [No Abstract]   [Full Text] [Related]  

  • 23. Pemphigus in a patient treated with penicillamine for generalized morphea.
    Davies MG; Holt P
    Arch Dermatol; 1976 Sep; 112(9):1308-9. PubMed ID: 136927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annular keratotic papules on the extremities.
    Bennett JA; Clarke JT; Ioffreda MD
    J Am Acad Dermatol; 2015 Nov; 73(5):891-3. PubMed ID: 26475551
    [No Abstract]   [Full Text] [Related]  

  • 25. A rare association of localized scleroderma type morphea, vitiligo, autoimmune hypothyroidism, pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case report.
    Bonilla-Abadía F; Muñoz-Buitrón E; Ochoa CD; Carrascal E; Cañas CA
    BMC Res Notes; 2012 Dec; 5():689. PubMed ID: 23256875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphea associated with the use of adalimumab: a case report and review of the literature.
    Ramírez J; Hernández MV; Galve J; Cañete JD; Sanmartí R
    Mod Rheumatol; 2012 Aug; 22(4):602-4. PubMed ID: 22095405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
    J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced morphea: autoimmunity as a risk factor.
    Machan A; Oumakhir S; Khalidi M; Hjira N; Boui M
    Neth J Med; 2019 Jan; 77(1):29-31. PubMed ID: 30774102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
    Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
    Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug induction in connective tissue diseases.
    Verdelli A; Antiga E; Bonciolini V; Bonciani D; Volpi W; Caproni M
    G Ital Dermatol Venereol; 2014 Oct; 149(5):573-80. PubMed ID: 24975950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillamine-induced polymyositis.
    Leden I; Libelius R
    Scand J Rheumatol; 1985; 14(1):90-3. PubMed ID: 4001884
    [No Abstract]   [Full Text] [Related]  

  • 32. Bullous pemphigoid and penicillamine.
    Weller R; White MI
    Clin Exp Dermatol; 1996 Mar; 21(2):121-2. PubMed ID: 8759198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast enlargement induced by D-penicillamine.
    Tchebiner JZ
    Ann Pharmacother; 2002 Mar; 36(3):444-5. PubMed ID: 11895058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymptomatic annular plaques on the neck.
    Chabra IS; Grandinetti LM
    Cutis; 2014 Oct; 94(4):E1-3. PubMed ID: 25372260
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Scleroderma, thyroiditis, and myasthenia gravis: study of a case].
    Werneck AL; Checcacci-Balod T; Tuma G
    Arq Neuropsiquiatr; 1993 Dec; 51(4):549-53. PubMed ID: 8147762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus.
    Nagao K; Tanikawa A; Yamamoto N; Amagai M
    Clin Exp Dermatol; 2005 Jan; 30(1):43-5. PubMed ID: 15663502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
    Musiał J; Undas A; Celińska-Lowenhoff M
    Rheumatology (Oxford); 2003 Dec; 42(12):1566-8. PubMed ID: 14645861
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of Hashimoto struma coinciding with limited scleroderma].
    Pethe K; Popenda G; Stasiów A
    Wiad Lek; 1992 Feb; 45(3-4):138-40. PubMed ID: 1413795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.
    Godar JM; Norins AL
    Arch Dermatol; 1992 Jul; 128(7):977-8, 980-1. PubMed ID: 1626968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.